Rote of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivo

被引:9
作者
Puhl, Sarah-Lena [1 ,2 ]
Weeks, Kate L. [1 ,3 ]
Guran, Alican [1 ]
Ranieri, Antonella [1 ]
Boknik, Peter [4 ]
Kirchhefer, Uwe [4 ]
Mueller, Frank U. [4 ]
Avkiran, Metin [1 ]
机构
[1] Kings Coll London, St Thomas Hosp, British Heart Fdn Ctr Res Excellence, Sch Cardiovasc Med & Sci, London SE1 7EH, England
[2] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Pettenkoferstr 9b, D-80336 Munich, Germany
[3] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[4] Univ Klinikum Munster, Inst Pharmakol & Toxikol, Domagkstr 12, D-48149 Munster, Germany
关键词
Protein phosphatases; Beta-adrenergic receptors; PP2A; Contractile function; Cardiac hypertrophy; BINDING-PROTEIN-C; RYR2; PHOSPHORYLATION; RYANODINE RECEPTOR; HEART-FAILURE; DILATED CARDIOMYOPATHY; TROPONIN-I; PP2A; HYPERPHOSPHORYLATION; PHOSPHOLAMBAN; MODULATION;
D O I
10.1093/cvr/cvy230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims B56 alpha is a protein phosphatase 2A (PP2A) regulatory subunit that is highly expressed in the heart. We previously reported that cardiomyocyte B56 alpha localizes to myofilaments under resting conditions and translocates to the cytosol in response to acute beta-adrenergic receptor (beta-AR) stimulation. Given the importance of reversible protein phosphorylation in modulating cardiac function during sympathetic stimulation, we hypothesized that loss of B56 alpha in mice with targeted disruption of the gene encoding B56 alpha (Ppp2r5a) would impact on cardiac responses to beta-AR stimulation in vivo. Methods and results Cardiac phenotype of mice heterozygous (HET) or homozygous (HOM) for the disrupted Ppp2r5a allele and wild type (WT) littermates was characterized under basal conditions and following acute beta-AR stimulation with dobutamine (DOB; 0.75 mg/kg i.p.) or sustained beta-AR stimulation by 2-week infusion of isoproterenol (ISO; 30 mg/kg/day s.c.). Left ventricular (LV) wall thicknesses, chamber dimensions and function were assessed by echocardiography, and heart tissue collected for gravimetric, histological, and biochemical analyses. Western blot analysis revealed partial and complete loss of B56 alpha protein in hearts from HET and HOM mice, respectively, and no changes in the expression of other PP2A regulatory, catalytic or scaffolding subunits. PP2A catalytic activity was reduced in hearts of both HET and HOM mice. There were no differences in the basal cardiac phenotype between genotypes. Acute DOB stimulation induced the expected inotropic response in WT and HET mice, which was attenuated in HOM mice. In contrast, DOB-induced increases in heart rate were unaffected by B56 alpha deficiency. In WT mice, ISO infusion increased LV wall thicknesses, cardiomyocyte area and ventricular mass, without LV dilation, systolic dysfunction, collagen deposition or foetal gene expression. The hypertrophic response to ISO was blunted in mice deficient for B56 alpha. Conclusion These findings identify B56 alpha as a potential regulator of cardiac structure and function during beta-AR stimulation.
引用
收藏
页码:519 / 529
页数:11
相关论文
共 44 条
[31]   Exercise attenuates inflammation and limits scar thinning after myocardial infarction in mice [J].
Puhl, Sarah-Lena ;
Mueller, Andreas ;
Wagner, Michael ;
Devaux, Yvan ;
Boehm, Michael ;
Wagner, Daniel R. ;
Maack, Christoph .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (02) :H345-H359
[32]   β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573 [J].
Ranieri, Antonella ;
Kemp, Elizabeth ;
Burgoyne, Joseph R. ;
Avkiran, Metin .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 115 :20-31
[33]   Role of RyR2 Phosphorylation at S2814 During Heart Failure Progression [J].
Respress, Jonathan L. ;
van Oort, Ralph J. ;
Li, Na ;
Rolim, Natale ;
Dixit, Sayali S. ;
deAlmeida, Angela ;
Voigt, Niels ;
Lawrence, William S. ;
Skapura, Darlene G. ;
Skardal, Kristine ;
Wisloff, Ulrik ;
Wieland, Thomas ;
Ai, Xun ;
Pogwizd, Steven M. ;
Dobrev, Dobromir ;
Wehrens, Xander H. T. .
CIRCULATION RESEARCH, 2012, 110 (11) :1474-+
[34]   Cardiac myosin-binding protein-C phosphorylation and cardiac function [J].
Sadayappan, S ;
Gulick, J ;
Osinska, H ;
Martin, LA ;
Hahn, HS ;
Dorn, GW ;
Klevitsky, R ;
Seidman, CE ;
Seidman, JG ;
Robbins, J .
CIRCULATION RESEARCH, 2005, 97 (11) :1156-1163
[35]   Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban [J].
Schmitt, JP ;
Kamisago, M ;
Asahi, M ;
Li, GH ;
Ahmad, F ;
Mende, U ;
Kranias, EG ;
MacLennan, DH ;
Seidman, JG ;
Seidman, CE .
SCIENCE, 2003, 299 (5611) :1410-1413
[36]  
Slupe Andrew M, 2011, Enzyme Res, V2011, P398751, DOI 10.4061/2011/398751
[37]   Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins [J].
Solaro, R. John .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (40) :26829-26833
[38]   miR-1 Overexpression Enhances Ca2+ Release and Promotes Cardiac Arrhythmogenesis by Targeting PP2A Regulatory Subunit B56α and Causing CaMKII-Dependent Hyperphosphorylation of RyR2 [J].
Terentyev, Dmitry ;
Belevych, Andriy E. ;
Terentyeva, Radmila ;
Martin, Mickey M. ;
Malana, Geraldine E. ;
Kuhn, Donald E. ;
Abdellatif, Maha ;
Feldman, David S. ;
Elton, Terry S. ;
Gyoerke, Sandor .
CIRCULATION RESEARCH, 2009, 104 (04) :514-521
[39]   The Dilated Cardiomyopathy-Causing Mutation ACTC E361G in Cardiac Muscle Myofibrils Specifically Abolishes Modulation of Ca2+ Regulation by Phosphorylation of Troponin I [J].
Vikhorev, Petr G. ;
Song, Weihua ;
Wilkinson, Ross ;
Copeland, O'Neal ;
Messer, Andrew E. ;
Ferenczi, Michael A. ;
Marston, Steven B. .
BIOPHYSICAL JOURNAL, 2014, 107 (10) :2369-2380
[40]   From Promiscuity to Precision: Protein Phosphatases Get a Makeover [J].
Virshup, David M. ;
Shenolikar, Shirish .
MOLECULAR CELL, 2009, 33 (05) :537-545